Bioactivity-guided screening identifies pheophytin a as a potent anti-hepatitis C virus compound from Lonicera hypoglauca Miq.
- 24 July 2009
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 385 (2), 230-235
- https://doi.org/10.1016/j.bbrc.2009.05.043
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Relative Replication Capacity and Selective Advantage Profiles of Protease Inhibitor-Resistant Hepatitis C Virus (HCV) NS3 Protease Mutants in the HCV Genotype 1b Replicon SystemAntimicrobial Agents and Chemotherapy, 2008
- Phenotypic Characterization of Resistant Val 36 Variants of Hepatitis C Virus NS3-4A Serine ProteaseAntimicrobial Agents and Chemotherapy, 2008
- Cell culture and infection system for hepatitis C virusNature Protocols, 2006
- Combined Interferon and Ribavirin Therapy for Chronic Hepatitis C in TaiwanIntervirology, 2005
- Antiviral compounds from traditional Chinese medicines Galla Chinese as inhibitors of HCV NS3 proteaseBioorganic & Medicinal Chemistry Letters, 2004
- Synergistic Inhibition of Intracellular Hepatitis C Virus Replication by Combination of Ribavirin and Interferon‐αThe Journal of Infectious Diseases, 2004
- Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cellsHepatology, 2004
- An NS3 Serine Protease Inhibitor Abrogates Replication of Subgenomic Hepatitis C Virus RNAJournal of Biological Chemistry, 2003
- Efficient Initiation of HCV RNA Replication in Cell CultureScience, 2000
- Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell LineScience, 1999